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Prostate cancer is initially treated via androgen deprivation therapy (ADT), a highly successful treatment in
the initial pursuit of tumour regression, but commonly restricted by the eventual emergence of a more
lethal ‘castrate resistant’ (CRPC) form of the disease. Intracrine pathways that utilize
dehydroepiandrosterone (DHEA) or other circulatory precursor steroids are thought to generate relevant
levels of growth-stimulating androgens such as testosterone (T) and dihydrotestosterone (DHT).
Decoding this tissue-specific metabolic pathway is key for the development of novel therapeutic
treatments. Mass spectrometry imaging (MSI) is an analytical technique that allows the visualization of the
distribution of numerous classes of biomolecules within tissue sections. The analysis of androgens by liquid
chromatography mass spectrometry (LC/MS)-based methods however presents a challenge due to their
generally poor ionization efficiency and low physiological endogenous levels. In MSI, on-tissue chemical
derivatization (OTCD) has enabled the limits of steroids to be imaged within tissues to be pushed by
overcoming poor ionization performance. However, isobaric interference of key androgen derivatives such as
T and DHEA can severely hamper studying the intracrinology in several diseases. Here, we have evaluated the
use of laser induced post-ionization (MALDI-2) combined with trapped ion mobility separation (TIMS) and
orthogonal time-of-flight (QTOF) MS for the visualization of isobaric derivatized androgens in murine tumour
xenograft at about 50 mm spatial resolution. With this combination, isobaric T and DHEA were separated in
tissue sections and the signals of derivatized steroids enhanced by about 20 times. The combination of TIMS
and MALDI-2 thus shows unique potential to study tissue intracrinology within target tissues. This could offer
the opportunity for many novel insights into tissue-specific androgen biology.Introduction
Advanced localized prostate cancer (PCa) is commonly treated
by androgen deprivation therapy (ADT).1 The primary goal of
this treatment is to decrease the levels of circulatory androgens,University of Edinburgh, Scotland, UK
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925such as testosterone (T) and to block tumour cell growth.
Castrate resistant prostate cancer (CRPC) is a more lethal and
difficult form of PCa to treat and it is currently under debate on
how this alternative form has originated.1–3 Steroid intra-
crinology was rst acknowledged by Labrie et al.,4 in which
castrated rats obtained the ability to maintain levels of T and
dihydrotestosterone (DHT). These potent androgen receptor acti-
vating ligands, by conversion mechanisms contained within the
prostatic tumour tissue, are synthesized using the adrenal precursor
dehydroepiandrosterone (DHEA).5 The retention of androgen sig-
nalling has been suggested upon this mechanism of intracrine
conversion, with numerous studies showing the presence of
a different androgen metabolism pathway as shown in Fig. 1.1,5
Therefore, unravelling this tissue-specic metabolic pathway is key
for the development of novel therapeutic treatments.
Mass spectrometry imaging (MSI) is a versatile andmultiplex
analytical method, allowing the production of a 2D ion image of
multiple metabolites in biological tissues.6 Androgens have
been demonstrated to show poor ionization efficiency in liquid© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 1 Main castrate resistant prostate cancer (CRPC) androgen


























































































View Article Onlinechromatography/mass spectrometry (LC/MS) analysis due to the
lack of both hydrogen donor or acceptor moieties. Moreover,
their physiological endogenous levels are generally low.7
Chemical derivatization (CD) approaches have been extensively
used in LC/MS-based platforms in order to enhance ion
production yields. In combination with matrix-assisted laser
desorption ionization (MALDI) MSI, on-tissue chemical deriva-
tization (OTCD) has been able to push the limits of steroid
imaging within tissues by increasing signal intensity and over-
coming poor ionization performance.8,9 Previous studies have
demonstrated the use of hydrazine-based derivatization
reagents in androgen MSI for murine tissue sections.10,11
However, isobaric interference of key derivatized androgens
such as T and DHEA, along with ion suppression effects, remain
an issue as both androgen derivatives share the same mono-
isotopic mass and the same fragmentation patterns upon
several dissociation mechanisms.10
To overcome these issues, we here assessed, for the rst
time, the use of laser-induced post-ionization (MALDI-2),
combined with trapped ion mobility separation (TIMS)
(MALDI-2-TIMS) in the identication and distribution analysis
of isobaric derivatized androgen in a murine tumour xenogra
model. MALDI-2 is a recently introduced method for enhanced
MSI of numerous classes of biomolecules including sterols,12 in
tissue sections at high lateral resolution.13
In this proof of concept study, two derivatization reagents,
namely Girard-T (GT) and Dansyl Hydrazine (DS) were evaluated
using a timsTOF eX MALDI-2 platform from Bruker. The laser-
induced post-ionization process signicantly improved sensi-
tivity of the derivatized androgens and TIMS provided fast
orthogonal separation that efficiently unravels isobaric
androgen spectra. The result is not only the ability to extract
mass information from single isobars, but also to differ isobars
based on their different collisional cross sections (CCS) and
hence ion mobility dri times. In this way, the spatial distri-
bution of both DHEA and T in a murine xenogra model was
achieved.Results and discussion
Off-tissue derivatization screening and TIMS separation
This novel application of OTCD coupled with MALDI-2 and
TIMS enhanced on-tissue detection by laser induced post-© 2021 The Author(s). Published by the Royal Society of Chemistryionization on readily charged androgen derivatives and
allowed separation of endogenous isobaric androgen deriva-
tives, which yielded intense signal and distinct gas-phase
conformations upon TIMS analysis.
In this study, two hydrazine-based derivatization reagents
were evaluated using previously described optimized reaction
conditions8–10 to investigate the MALDI-2 signal enhancement
and TIMS mobility separation performance (Fig. S1†). These
reagents (Girard-T (GT) and Dansyl Hydrazine (DS)) (Fig. S1†)
were screened off and on-tissue, and instrument parameters
were optimized.
As shown in Fig. S2a,† testosterone GT-derivative (GT-T) was
detected at m/z 402.3138 as a molecular ion (M+) with a mass
accuracy (deviation from the calculated mass) of 5.7 ppm and
a signal intensity of 5 106. Its sodium adduct was also observed
at m/z 424.2947 [M + Na]+ with a mass accuracy of 2.8 ppm and
a signal intensity of 5.5  105. Fig. S2b† displays dehydroepian-
drosterone GT-DHEA detected at m/z 402.3143 (M+) with a mass
accuracy of 6.9 ppm and a signal intensity of 6  106. Its sodium
adduct was also detected at m/z 424.2946 [M + Na]+ with a mass
accuracy of 2.6 ppm and a signal intensity of 1  106.
That both androgen derivatives displayed a sodium adduct is
an interesting nding since these charged derivatives possess
a quaternary amine moiety and sodium adduct formation
therefore was not expected. Also, the detection of these ion
species was not reported previously in the MALDI analysis of
hydrazone derivatives. The adduct formation mechanism may
be explained by the thermal proton transfer model,14 in which
the absorption of laser light by matrix molecules results in an
increased temperature, upon which the solid matrix melts and
behaves in a similar manner to a polar solvent, before the
occurrence of desorption. Adducts may then be generated by
thermally induced reactions in a polar solvent-like matrix by
proton transfer from the quaternary amine.
On the other hand, as is shown in Fig. S2c,† testosterone
DS derivative (DS-T) displays a protonated mass at m/z 536.2942
[M + H]+ with a mass accuracy of 0.2 ppm and a signal intensity of
4 105. Sodiated adduct was also found atm/z 558.2757 [M + Na]+
with a mass accuracy of 0.7 ppm and a signal intensity of 2 
105. The DHEA-DS derivative (DS-DHEA) was also detected
(Fig. S2d†) as a radical cation at m/z 535.2868 (M+c) with a mass
accuracy of 0.9 ppm at 3.5  105 signal intensity and as a sodium
adduct at m/z 558.2750 [M + Na]+ with a mass accuracy of
2.0 ppm and a signal intensity of 1.5  105.
It is important to note that even though both androgen
derivatives can be resolved by mass, as DS-T is detected as
protonated mass and DS-DHEA as radical cation, DS-T deriva-
tive may suffer from isobaric interference from the 13C isotope
peak of DS-DHEA unless using ultra-high mass resolution
analysers such as FT-ICR. The different behaviour of DS-
derivatives regarding pseudomolecular ion formation may be
attributable to their molecular structure. The protonation site of
DS-T derivative could be either at the nitrogen of tertiary amine
or hydrazine groups. In both scenarios the charge can be
stabilized by the p–p system which, in case of testosterone, is
extended to the steroid A ring due to its a,b-unsaturated
carbonyl system at C4. Since DHEA-DS lacks this conjugatedRSC Adv., 2021, 11, 33916–33925 | 33917
Fig. 2 Off-tissue mobility assessment of Girard-T-derivatized androgens by MALDI-2-TIMS-tof mass spectrometry. Mobilograms of derivatized
(a) testosterone (M+ signal at m/z 402.3138) showing two ion mobility signals with central 1/K0 values at 1.190 and 1.208, respectively. (b) DHEA
M+ signal at m/z 402.3143 showing a single ion mobility signal at 1.195 1/K0. (c) Testosterone ([M + Na]
+ at m/z 424.2947) showing a single ion
mobility signal at 1.251 1/K0. (d) DHEA ([M + Na]
+ at m/z 424.2946) showing a single ion mobility signal at 1.227 1/K0. (e) Equimolar solution of
isobaric T and DHEA (100 ng mL1, each) showing two ion mobility signals at 1.210 1/K0 (T) and 1.195 1/K0 (DHEA) for the at M
+ ion. (f) Data from
the same equimolar solution for the [M + Na]+ species of T and DHEA showing two ion mobility signals at 1.251 1/K0 (T) and 1.227 1/K0 (DHEA).
Signal intensity is depicted by colour on the scales shown.



























































































Fig. 3 Off-tissue mobility assessment of dansyl hydrazine-derivatized androgens by MALDI-TIMS-tof mass spectrometry. Mobilograms of
derivatized (a) testosterone [M + H]+ signal at m/z 536.2942 showing two ion mobility signals with central 1/K0 values at 1.296 and 1.253,
respectively. (b) DHEAM+* signal atm/z 535.2868 showing a single ionmobility signal at 1.344 1/K0. (c) Testosterone ([M + Na]
+ atm/z 558.2750)
showing two ion mobility signals at 1.394 and 1.353 1/K0. (d) DHEA ([M + Na]
+ atm/z 558.2750) showing a single ion mobility signal at 1.381 1/K0.
(e) Equimolar solution of isobaric T and DHEA (100 ng mL1, each) [M + H]+ atm/z 536.2940 (T) showing a single ion mobility signal at 1.344 1/K0
(T) and M+* (DHEA) at m/z 535.2865 showing two ion mobility signals with central 1/K0 values at 1.296 and 1.253 (DHEA), respectively. (f) Data
from the same equimolar solution for the [M + Na]+ species of T and DHEA showing two ion mobility signals at 1.353 1/K0 (T) and 1.381 1/K0
(DHEA). Signal intensity is depicted by colour on the scales shown.




















































































































































































View Article Onlinesystem, protonation is less energetically favoured, thus a radical
cation may be formed by losing one electron from either the
hydrazine or tertiary amine nitrogen by direct photo/thermal
mechanism during the ionization process.
Isobaric GT-androgen derivatives were then subjected to
TIMS separation based on their CCS. As shown in Fig. 2a, GT-T
derivative exhibited two mobility signals at 1/K0 values of 1.208
and 1.190, presumably corresponding to its cis–trans isomeric
structures across the enamine moiety double bond (C]N) on
the A ring at C3. In contrast, the DHEA-GT derivative displayed
only one mobility signal at 1.195 1/K0 (Fig. 2b) as the two
isomeric structures could not be resolved, probably due to
possible steric hindrance effects from themethyl group near the
enamine moiety on the D ring at C17. Their sodiated adducts
were also assessed and, interestingly displayed high, intensely
distinct mobility signals at 1.251 1/K0 for GT-T (Fig. 2c) and
1.227 1/K0 for GT-DHEA (Fig. 2d).
If analysed from an equimolar mixture, the two isobaric
androgen derivatives were resolved at M+ at 1.210 1/K0 for GT-T
and 1.195 1/K0 for GT-DHEA (Fig. 2e) and at [M + Na]
+ at 1.251
for GT-T and 1.227 for GT-DHEA with better resolution observed
for the sodium adducts (Fig. 2f). This data suggested that there
is a potential overlap of one GT-T isomer at 1.190 1/K0 with the
GT-DHEA at 1.195 1/K0 at M
+.
Mobilograms for dansyl derivatives are shown in Fig. 3.
Protonated DS-T derivative exhibited two mobility signals at
1.296 and 1.253 1/K0 corresponding to its corresponding cis–
trans isomeric structures, as previously observed for GT-
derivatives (Fig. 3a). The radical DS-DHEA derivative only
shows one intense mobility signal at 1.344 1/K0 (Fig. 3b).
Regarding their sodium adducts, DS-T displayed two mobility
signals at 1.394 and 1.353 1/K0 with only one signal observed for
DS-DHEA at 1.381 1/K0, as shown in Fig. 3c and d.
From an equimolar mixture the two androgens derivatives
were successfully resolved at [M + H]+ at 1.296/1.253 1/K0 for DS-
T and at M+c1.344 1/K0 for DS-DHEA (Fig. 3e). They were also
resolved at [M + Na]+ mobility signals detected at 1.353 for GT-T
and 1.381 1/K0 for GT-DHEA (Fig. 3f), with a better mobility
resolution observed for the protonated/radical ions.On-tissue derivatisation screening and MALDI-2-TIMS-tof MSI
assessment
Signal enhancement upon laser-induced post-ionization was
evaluated on tumour xenogra tissue, in which the levels of
endogenous tumour T and DHEA are high (around 20 ng g1) as
determined by LC/MS. Tissue sections were derivatized using
both GT and DS reagents as described in the methods section.
As clearly shown in Fig. 4a, GT-derivatives did not exhibit any
signal enhancement upon MALDI-2. Since GT derivatives are
already charged species, they apparently do not benet from the
MALDI-2 process. Similar observations have been made previ-
ously for example for quaternary phosphatidylcholines.15,16 On
the contrary, signal intensity of DS-derivatives (accumulation of
20 random walk scans across the tissue) was enhanced upon
MALDI-2 by about 20 times for DS-DHEA and 40 times for DS-T
derivatives (Fig. 4b).33920 | RSC Adv., 2021, 11, 33916–33925Since DS-derivatives are not charged species, they are more
susceptible to ion suppression effects than GT-charged deriva-
tives. In this case, MALDI-2 has substantially improved on-
tissue signal intensity of DS-androgen derivatives.
The distributions of the endogenous isobaric androgens in
the tissue was also assessed with and without MALDI-2. Signal
of endogenous DS androgen derivatives without laser-induced
post-ionization was considerable reduced as signal intensity
for both DS derivatives were suppressed; for the DS-T derivative,
the signal was almost undetectable as displayed in Fig. 4c. As
a result, the MSI image of DS-DHEA atm/z 535.2862 (sum of cis–
trans isomers at 1.381 and 1.345 1/K0) and DS-T at m/z 536.2948
(sum of cis–trans isomers at 1.296 and 1.253 1/K0) displayed low
signal intensity, as shown in Fig. 4d and e, respectively. Upon
enabling MALDI-2, tissue signal on the selected region of
interest (ROI) was greatly improved, as shown in Fig. 4f.
Consequently, MSI images signal intensities of DS-DHEA at m/z
535.2862 and DS-T at m/z 536.2948 were enhanced by approxi-
mately 5 times for DS-DHEA and by about 20 times for DS-T, as
is shown in Fig. 4g and h respectively.Distribution of endogenous T and DHEA in LNCaP mouse
xenogra tissues by OTCD-MALDI-2-TIMS-tof
For the rst time, isobaric T and DHEA were successfully
detected and resolved, and their spatial distribution was
assessed in murine xenogra tissues using the OTCD-MALDI-2-
TIMS-tof MSI platform. Understanding the distribution of these
androgens in the prostate tumour is strategic at aiming to
establish how potential effects of a tumour environment may
have on the intracrine pathway of steroidogenesis. It is also key
to design therapeutic treatment that may cause desirable effects
to reduce the formation of cancer cells.
For molecular mapping of these androgens, GT was selected
as derivatization reagent, because this achieved the best signal
intensity and well-resolved mobilograms using sodium adducts
for both T and DHEA derivatives.
As shown in Fig. 5, endogenous T and DHEA were detected as
GT derivatives at m/z 424.2947, corresponding to the [M + Na]+
species with a mass accuracy of 2.3 ppm (Fig. 5i). T and DHEA
were successful resolved by their distinct CCS of their sodium
adducts at 1.259 1/K0 and 1.231 1/K0, respectively, as shown in
Fig. 5a. Spatial distributions shown discrete localization within
the tumour tissue with perfect co-localization were observed for
both steroids (Fig. 5c and d).
Histological staining with haematoxylin and eosin (H&E)
(Fig. 5b) was used to assess if any distinctmorphological regions or
differential cell types could be observed in the tissue that may be
related to the intracrine conversion of androgens. The distribu-
tions of T and DHEA showed potential areas of differentiation, as
indicated in Fig. 5e and f. Amagnication is indicated up to 5 on
the tissue regions of interest indicated in Fig. 5g.
Uponmagnication, blood cells were distinguished from the
mesenchymal stroma cells present, displaying nuclei stained as
the darker coloured purple spots at 5. Basal cells of the stroma
are also observed as the uniform cells bordering the darker
tissue staining of the blood vessels (highlighted in red). The© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 4 OTCD-MALDI-2-TIMS-tof MS imaging analysis of endogenous androgens as hydrazone derivatives in LNCaP tumour control tissue from
a xenograft mouse model. (a) MALDI-2-TIMS-tof MS analysis (accumulation of 20 random walk scans across the tissue) of GT-derivatives of (I)
testosterone with MALDI-2 disabled, (IV) testosterone with MALDI-2 enabled, (III) DHEAwith MALDI-2 disabled, and (IV) DHEAMALDI-2 enabled.
For these derivatives, signal intensity was not enhanced upon activation of laser-induced post-ionization. (b) MALDI-2-tof MSI analysis of DS-
derivatives. Signal intensity was considerably enhanced upon use of laser post-ionization: (I) testosterone measured with MALDI-2 disabled, (II)
testosteronewithMALDI-2 enabled. (III) DHEAwithMALDI-2 disabled, and (IV) DHEAwithMALDI-2 enabled. Mobilograms of DS-T andDS-DHEA
derivatives: (c) without MALDI-2, (f) with MALDI-2 enabled. MSI image (whole tissue) reconstruction along with box-plot signal intensity for the
DS-DHEA derivative (M+c) at m/z 535.2862 (sum of cis–trans isomers at 1.381 and 1.345 1/K0): (d) without MALDI-2 enabled, (g) with MALDI-2
enabled. DS-T [M + H]+ at m/z 536.2948 (sum of cis–trans isomers at 1.296 and 1.253 1/K0): (e) without MALDI-2, (h) with MALDI-2 enabled.
Signal intensity is depicted by colour on the scales shown. Scale bar, 3 mm.



























































































Fig. 5 OTCD-MALDI-TIMS-tof MS imaging of androgens as Girard-T hydrazone derivatives of LNCaP tumour control tissue from a xenograft
mouse. Molecular distribution of endogenous isobaric androgens detected as GT-derivatives in an LNCaP tumour control tissue from a xenograft
mouse section by OTCD-MALDI-TIMS-tof-MSI platform. (a) Representative single-pixel mobilograms of isobaric androgens: GT-derivatives ([M
+ Na]+ at m/z 424.2940) detected at 1.259 1/K0 for testosterone and at 1.231 1/K0 for DHEA. (b) Representative H&E-stained adjacent tissue
section. Molecular distribution map of (c) GT-T derivative ([M + Na]+,m/z 424.2940  0.005, 1.251 1/K0) (d) GT-DHEA derivative ([M + Na]+,m/z
424.2940 0.005, 1.231 1/K0). (e) Molecular distributionmap of GT-testosterone derivative ([M + Na]+ atm/z 424.2940, 1.259 1/K0) with high ion
abundance areas highlighted. (f) Representative H&E-stained tissue with high ion abundance areas highlighted. (g) Magnified image obtained
with 5 zoom of areas indicated; (h) representative single pixel isobaric sodium adduct mass spectrum of (I) GT-T derivative, (II) GT-DHEA
derivative. Signal intensity is depicted by colour on the scales shown. Scale bar, 3 mm.




















































































































































































View Article Onlineblood vessels were less uniform and looked disordered within
the tissue stains. No further differentiation of cell types was
observed at these potential sites, and no distinct cell types were
observed when correlating them with derivatized androgen
signal detected. To conrm the identication of both active
androgens in the tumour tissue, LC/MS was performed on
tissue homogenate, giving a concentration of 31 pg g1 for T
and 52 pg g1 for DHEA (Fig. S5†).Conclusions
OTCD-MALDI-2-TIMS-tof MSI is a powerful new tool to study
the spatial distribution of derivatized isobaric androgens within
tissues. Here, we have demonstrated the ability of the method
for visualization of testosterone and DHEA, two biological
exceedingly relevant androgens. We have also demonstrated the
utility of the method for detecting endogenous concentrations
within murine xenogra tissue, a key tissue model for prostate
cancer intracrinology at 50 mm spatial resolution. Our proof of
principle study strongly benetted from the use of MALDI-2, as
this technology not only enables the detection of native
steroids, but advantageously also enhances the analytical
sensitivity of more readily ionizable androgens derivatives by
about ve times and by reducing ion suppression effects. The
additional TIMS unit, available with the employed mass spec-
trometer, provided fast orthogonal separation of the ions
according to their individual CCS values. This feature efficiently
unravelled these isobaric spectra. The combination of TIMS and
MALDI-2 has shown to be a uniquely powerful platform to study
tissue intracrinology within target tissues.
This offers the opportunity for many novel insights into tissue-
specic androgens biology. Importantly, the use of this platform
facilitates the analysis of previously inaccessible biologically rele-
vant isobaric steroids through adaptation of existing chemical
derivatisation methods. This platform may be applicable to other
carbonyl containing molecules such as aldehydes, enolates and
also amides/esters, in which case, will be feasible prior carbonyl
activation. This technique may also be extended to study other
poor ionisable carbonyl-containing molecules in biological rele-
vant tissues such as kidney, brain and adrenal gland.Experimental
Chemicals
Testosterone and dehydroepiandrosterone (DHEA) were
purchased separately as 1 mg mL1 solutions in methanol from
Steraloids Inc. (Newport, RI); d3-testosterone (ISTD for LC/MS)
was purchased form Sigma Aldrich (Dorset, UK). Girard-T (GT)
reagent, Dansyl Hydrazine (DS), a-cyano-4-hydroxycinnamic
acid (CHCA), acetonitrile, methanol, acetone, ethanol, tri-
uoroacetic acid (TFA) and HPLC grade water were all obtained
from Sigma Aldrich (Dorset, UK).Cell line and culture conditions
LNCaP cell line was obtained from the European Collection of
Authenticated Cell Cultures (LNCaP clone FGC (ECACC© 2021 The Author(s). Published by the Royal Society of Chemistry89110211), Salisbury, UK) and maintained in RPMI1640 media
with 10% foetal bovine serum (FBS), 1% penicillin/streptomycin
and 1% L-glutamine (Fisher Scientic, Loughborough, UK).
Cells were kept at 37 C in a 5% CO2 environment.
In vivo LNCaP mouse xenogra model
Experiments were conducted in accordance with the Animal
(Scientic Procedures) Act 1986. All animal procedures were
performed in accordance with the Guidelines for Care and Use
of Laboratory Animals of Ulster University and approved by the
Animal Ethics Committee of Ulster University. Male nude CD-1
mice (aged 6–8 weeks, weighing approximately 27–34 g) were
housed at room temperature of 20–24 C, with a 12 h light/dark
cycle. Animals were housed in individually ventilated cages with
up to 5 mice per cage, with standard certied diet food and
water ad libitum. LNCaP human prostate cancer cells (1  107
suspended in Matrigel) were implanted subcutaneously onto
the ank of the mice using a 25-gauge needle. When the tumour
volume reached approximately 100–150 mm3, mice were sub-
jected to treatment. Mice were dosed with DHEA (dissolved in
vehicle solution) at 0.5 mg kg1 and administered by intraperi-
toneal route (IP). All surgical procedures were performed under
aseptic conditions, and the body temperature of the animals
was kept constant using heated pads. Animals were sacriced at
the appropriate time points by CO2 overdosage, followed by
conrmatory cervical dislocation. Tumour tissues were excised
at termination, snap frozen in chill isopentane and stored at
80 C before further use.
Tissue sectioning and mounting
LNCaP xenogra tumour was used for the MSI studies. Tissues
were cut in a way that mimics a sagittal plane of slicing, as there
is no spatial orientation with xenogra tumour. Cryosectioning
was performed using a Leica cryotome (CM 1850 UV, Wetzlar,
GmbH & Co. KG) at18 C and 12 mm tissue thickness. Sections
were thaw-mounted onto conductive indium-tin-oxide (ITO)-
coated slides (Bruker Daltonik, Bremen, GmbH & Co. KG),
dried in a vacuum desiccator at room temperature for 30 min,
and then stored at 80 C until MSI analysis.
Histological staining
See ESI† for method description.
Off-tissue derivatization screening and TIMS separation
See ESI† for method description.
OTCD reagent application for LNCaP xenogra tumour
MALDI-2 assessment and imaging
From 80 C, tumour tissue sections were dried in a vacuum
desiccator (RT, 20 min). Gir-T and dansyl hydrazine reagents
were dissolved at 0.1 mg mL1 in 90 : 10 : 0.1 (v/v/v) meth-
anol : water : triuoroacetic acid (TFA) (10 mL) and were intro-
duced to the ImagePrep® device (Bruker Daltonik, Bremen
GmbH & Co. KG). A custom-edited method was created on the


























































































View Article Onlineet al.17 One-step was programmed to run for approximately 1
hour to achieve reaction completion. Conditions were as
follows; ‘matrix thickness’ was manual set to 40 cycles, spray
power at 25% and a xed spray time of 2.2 s. Incubation time
was set at 30 s with a xed drying time of 60 s, which led to
a nal OTCD time of approximately 60 min per slide and
a reagent density of 0.05 mg cm2 for GT and 0.06 mg cm2 for
DS. The ImagePrep has an in-built sensor that is designed to
monitor and control the thickness of MALDImatrices applied to
sample slides. However, this feature was not used for reagent
application.
Matrix application
CHCA (6 mL, 5 mg mL1 in 70 : 30 (v/v) acetonitrile : water +
0.1% v/v TFA) was applied in four passes using a modied 3D
printer, as described in Tucker et al.18 A ow rate of 0.1
mL min1 with a gas pressure of 2 bar, bed temperature of
30 C, a z-height of 30mm and stage velocity of 1100mmmin1,
averaging a run time of 24 min per slide. A uniform coating of
matrix was achieved with a coverage of 0.11 mg cm2. Matrix
deposition conditions were evaluated—see ESI† for further
details.
MALDI-TIMS-tof MSI analysis
LNCaP mouse xenogra tumour and mouse prostate control
tissues were analysed by MALDI-TIMS-tof MSI with and without
laser-induced post-ionization for derivatized androgens. Data
was acquired on a prototype timsTOF eX MALDI-2 instrument
(Bruker Daltonik, GmbH & Co. KG). MALDI was achieved with
a Smartbeam 3D laser operating at 10 kHz for MALDI-1. Laser
power was adjusted for each experiment to give the best
resulting data. Laser focus was set to the minimum diameter
and optimized to produce ablation craters of approximately 5
mm diameter. For imaging, pixel size was set to 50 mm in both X
and Y axis and a beam scan of 46 mm, respectively, to investigate
the full pixel area. Laser-induced post-ionization was achieved
using a diode-pumped, actively Q-switched, frequency-
quadrupled Nd:YAG laser operated at 1 kHz (NL 204-1k-FH,
EKS-PLA, Vilnius, Lithuania) as described previously.12 The
instrument was operated in positive ion mode, and ions
between m/z 300 and 800 were accumulated from 769 laser
shots per 50 mm pixel. For TIMS analysis, a ramp time of 769 ms
was chosen including a range for 1/K0 from 1.1 to 1.75 Vs cm
2.
Data analysis was performed with Data Analysis 5.3 (Build
342.363.6049, Bruker Daltonik, GmbH & Co. KG) and TIMS data
viewer 1.0 (Build 0.164; Bruker Daltonik, GmbH & Co. KG). The
resulting images were analysed using FlexImaging 5.0 (Build 80;
Bruker Daltonik, GmbH & Co. KG) and SCiLS lab soware (vs.
2021b; SCiLS Lab/Bruker Daltonik, GmbH & Co. KG).
Conrmatory LC-MS/MS analysis
Conrmatory LC-MS/MS analysis was performed using a triple-
quadrupole linear ion trap mass spectrometer (QTRAP 6500, AB
Sciex, Cheshire, UK) coupled with an ACQUITY ultra high-
pressure liquid chromatography system (UHPLC; Waters,
Wilmslow, UK). See ESI† for further details.33924 | RSC Adv., 2021, 11, 33916–33925AbbreviationsMALDI© 2021 The AuMatrix-assisted laser desorption/ionization
MALDI-2 Matrix-assisted laser desorption/ionization
combined with laser-induced post-ionization
TIMS Trapped ion mobility spectrometry
tof Time-of-ight
OTCD On-tissue chemical derivatization
CD Chemical derivatization
MSI Mass spectrometry imaging
T Testosterone
DHEA Dehydroepiandrosterone
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LC/MS Liquid chromatography/mass spectrometryAuthor contributions
D. C., C. L. L. M., and J. S. conceived and coordinated the
experiments. K. W. S., D. C., C. L. L. M., and J. S. designed the
experiments. K. W. S., J. S., B. H., D. C. and C. L. L. M. carried
out MS experiments. C. L. L. M., J. S., B. H., A. N.and D. C.
conducted data processing and analysis. K. D. and J. S. provided
equipment for MSI experiments. K. W. S., D. C., C. L. L. M., F. L.
C., J. S. and K. D. wrote the manuscript, which was edited by all
co-authors.
Conflicts of interest
The authors declare the following competing nancial inter-
est(s): A. N. is an employee of Bruker Daltonik GmbH & Co. KG
(Bremen, Germany); B. H. has been supported by Bruker Dal-
tonik during the cause of the project. All other authors declare
no conict of interest.
Acknowledgements
We acknowledge funding from the Department for Employment
and Learning (DEL) Northern Ireland (DEL 15226-C1, to D. C.
and K. W. S.), the Research Challenge Fund from Ulster
University (to D. C. and K. W. S.), and the German Research
Foundations (DFG; grants DR416/12-1 and SO976/3-1, project
number 290343045, to K. D. and J. S.).
References
1 K. H. Chang, R. S. Papari-Zareei, R. Watumull, L. Zhao,
Y. R. J. Auchus and N. Shari, Proc. Natl. Acad. Sci., 2011,
108, 13728–13733.
2 M. A. Perlmutter and H. Lepour, Rev. Urol., 2007, 9, 33–39.
3 S. M. Dehm and D. J. Tindall, J. Cell. Biochem., 2006, 99, 333–
344.
4 C. Labrie, A. Belanger and F. Labrie, Endocrinology, 1988,


























































































View Article Online5 G. Pignot, D. Maillet, E. Gross, P. Barthelemy, J. B. Beauval,
F. Constans-Schlurmann, Y. Loriot, G. Ploussard, P. Sargos
and M. O. Timsit, Nat. Rev. Urol., 2018, 15, 498–515.
6 K. Chughtai and R. M. A. Heeren, Chem. Rev., 2010, 110,
3237–3277.
7 T. Higashi, A. Yamauchi and K. Shimada, J. Chromatogr. B,
2005, 825, 214–222.
8 D. F. Cobice, D. E. W. Livingstone, A. McBride, C. L. Mackay,
B. R. Walker, S. P. Webster and R. Andrew, Biochem.
Pharmacol., 2018, 148, 88–99.
9 D. F. Cobice, C. L. Mackay, R. J. A. Goodwin, A. McBride,
P. Langridge-Smith, S. P. Webster, B. R. Walker and
R. Andrew, Anal. Chem., 2013, 85, 11576–11584.
10 D. F. Cobice, D. E. W. Livingstone, C. L. Mackay,
R. J. A. Goodwin, L. B. Smith, B. R. Walker and R. Andrew,
Anal. Chem., 2016, 88, 10362–10367.
11 S. Shimma, H. O. Kumada, H. Taniguchi, A. Konno, I. Yao,
K. Furuta, T. Matsuda and S. Ito, Anal. Bioanal. Chem.,
2015, 7607–7615.© 2021 The Author(s). Published by the Royal Society of Chemistry12 T. Bien, E. A. Hambleton, K. Dreisewerd and J. Soltwisch,
Anal. Bioanal. Chem., 2021, 413, 2767–2777.
13 J. Soltwisch, H. Kettling, S. Vens-Cappell, M. Wiegelmann,
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